We are working on the following new projects:

• We are preparing a contract for a phase 1 clinical trial with Dalteparin sodium.
• Our company signed a contract signature for the observational program with a top ten pharma.

We are happy to reach the following milestones in our projects:

• We received the Council of Ethics approval in the trial with COVID-19 vaccine.
• The enrollment was finished in the Spasmoanalgesic trial.
• The screening was performed in the Ibuprofen trial.